Acta OphthalmolAugust 2015Clinical Trial, Phase II
Efficacy and safety of SNJ-1656 in primary open-angle glaucoma or ocular hypertension.
No abstract available for this article.
More by Toshihiro Inoue
View full profile →YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
2018Invest Ophthalmol Vis Sci68 citations
Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity.
2016Invest Ophthalmol Vis Sci28 citations
Intraocular Pressure-Lowering Effects of Trabeculectomy Versus MicroShunt Insertion in Rabbit Eyes.
2021Transl Vis Sci Technol17 citations
Discussion
Comments and discussion will appear here in a future update.